Related Experiment Video
Updated: Nov 11, 2025

14:58
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
10.0K
Using of the Synthetic Dural Graft as Described in Bogota Bag Technique to Decrease the Adhesions in Decompressive
Ulas Yuksel1, Bulent Bakar, Alemiddin Ozdemir
1Kirikkale University, Faculty of Medicine, Department of Neurosurgery, Kirikkale, Turkey.
Turkish Neurosurgery
|March 24, 2021
Summary
A novel synthetic dural graft made from a polyvinyl chloride/polypropylene (PVC/PP) solution bag shows promise. This material may reduce adhesions and inflammation following craniectomy, suggesting potential use in neurosurgery.
Area of Science:
- Biomaterials Science
- Neurosurgery
- Regenerative Medicine
Background:
- Dural defects after craniectomy can lead to complications like adhesions.
- Developing biocompatible synthetic grafts is crucial for effective dural repair.
Purpose of the Study:
- To evaluate a novel synthetic dural graft created from a polyvinyl chloride/polypropylene (PVC/PP) parenteral solution bag.
- To assess the biocompatibility and efficacy of this synthetic graft in preventing adhesions and inflammation in a rat model.
Main Methods:
- A craniectomy model was established in 22 albino rats, divided into Sham, defect control (DC), and graft (BAG) groups.
- The PVC/PP graft was applied to the craniectomized site in the BAG group.
- Inflammatory markers and tissue reactions were assessed 30 days post-implantation.
Main Results:
- The synthetic graft significantly reduced fibrotic adhesions between brain tissue and scalp.
- No significant increase in inflammatory processes, foreign body reactions, toxicity, or infection was observed.
- Histological analysis showed compatibility with dermal and neural tissues.
Conclusions:
- The PVC/PP synthetic material demonstrates biocompatibility with dermal and neural tissues.
- This material effectively reduces adhesions in the craniectomy field.
- It holds potential as an alternative synthetic dural graft for decompressive craniectomy in humans, pending further toxicity studies.

